Health Technology Assessment
Author
Abstract
Suggested Citation
DOI: 10.1177/0272989X11424925
Download full text from publisher
References listed on IDEAS
- Yong Kim, Jim & Shakow, Aaron & Mate, Kedar & Vanderwarker, Chris & Gupta, Rajesh & Farmer, Paul, 2005. "Limited good and limited vision: multidrug-resistant tuberculosis and global health policy," Social Science & Medicine, Elsevier, vol. 61(4), pages 847-859, August.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- M. Beaulieu & P. Lehoux, 2019. "The emergence of health technology organizations among institutional healthcare and economic actors," International Entrepreneurship and Management Journal, Springer, vol. 15(4), pages 1115-1151, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Engel, Nora, 2009. "Innovation Dynamics in Tuberculosis Control in India: The Shift to New Partnerships," MERIT Working Papers 2009-040, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- McLaren, Z. & Burger, R., 2016. "A New Econometric Method for Estimating Disease Prevalence: An Application to Multi-Drug Resistant Tuberculosis," Health, Econometrics and Data Group (HEDG) Working Papers 16/26, HEDG, c/o Department of Economics, University of York.
- Austin, Kelly F. & DeScisciolo, Cristina & Samuelsen, Lene, 2016. "The Failures of Privatization: A Comparative Investigation of Tuberculosis Rates and the Structure of Healthcare in Less-Developed Nations, 1995–2010," World Development, Elsevier, vol. 78(C), pages 450-460.
- Amitabh Chandra & Anupam B. Jena & Jonathan S. Skinner, 2011.
"The Pragmatist's Guide to Comparative Effectiveness Research,"
Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 27-46, Spring.
- Amitabh Chandra & Anupam B. Jena & Jonathan S. Skinner, 2011. "The Pragmatist's Guide to Comparative Effectiveness Research," NBER Working Papers 16990, National Bureau of Economic Research, Inc.
More about this item
Keywords
randomized trial methodology; risk factor evaluation; population-based studies; scale development; HIV; AIDS; vulnerable populations; racial inequalities; access to care; equity in distribution/allocation; hospitalist or hospital medicine;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:32:y:2012:i:1:p:e20-e24. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.